KRAS and neuroblastoma: Although autophagy has been proposed as a mechanism of Id1 degradation in neuroblastoma cells [38], our data indicate that the autophagy inhibitor CQ does not affect the trametinib-mediated Id1 downregulation in KRAS-mutant LUAD cells.